Smartleaf Asset Management LLC reduced its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 2.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 2,131 shares of the company’s stock after selling 64 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Elevance Health were worth $786,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of ELV. Raelipskie Partnership acquired a new position in Elevance Health in the 3rd quarter valued at about $26,000. Crews Bank & Trust acquired a new position in Elevance Health in the 4th quarter valued at about $34,000. Dunhill Financial LLC grew its position in Elevance Health by 57.8% in the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock valued at $37,000 after acquiring an additional 26 shares in the last quarter. Peterson Financial Group Inc. acquired a new position in Elevance Health in the 3rd quarter valued at about $44,000. Finally, Financial Perspectives Inc acquired a new position in Elevance Health in the 4th quarter valued at about $50,000. 89.24% of the stock is owned by institutional investors and hedge funds.
Elevance Health Price Performance
ELV stock opened at $395.63 on Tuesday. The business has a 50 day moving average price of $388.27 and a 200 day moving average price of $437.33. The stock has a market cap of $89.95 billion, a price-to-earnings ratio of 15.45, a PEG ratio of 1.18 and a beta of 0.83. Elevance Health, Inc. has a fifty-two week low of $362.21 and a fifty-two week high of $567.26. The company has a quick ratio of 1.50, a current ratio of 1.45 and a debt-to-equity ratio of 0.71.
Elevance Health Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Monday, March 10th will be paid a $1.71 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $6.84 dividend on an annualized basis and a yield of 1.73%. This is a boost from Elevance Health’s previous quarterly dividend of $1.63. Elevance Health’s payout ratio is currently 26.71%.
Wall Street Analyst Weigh In
Several equities analysts have weighed in on ELV shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $485.00 target price on shares of Elevance Health in a research report on Friday, January 24th. Argus reissued a “hold” rating and set a $405.40 price objective on shares of Elevance Health in a research report on Wednesday, January 29th. Stephens downgraded Elevance Health from an “overweight” rating to an “equal weight” rating and lowered their price objective for the stock from $520.00 to $440.00 in a research report on Wednesday, January 22nd. StockNews.com raised Elevance Health from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Mizuho lowered their price objective on Elevance Health from $585.00 to $505.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. Three analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $517.03.
View Our Latest Stock Report on Elevance Health
Elevance Health Company Profile
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Featured Articles
- Five stocks we like better than Elevance Health
- How to Calculate Inflation Rate
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Investing in the High PE Growth Stocks
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Growth Stocks: What They Are, What They Are Not
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.